NCT06202599 2024-01-17
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Peking University People's Hospital
Completed
Clinical Trials
4 trialsNCT06202417 2024-01-11
Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study
Fudan University
Completed
NCT06031376 2023-09-11
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Completed
NCT05025631 2023-04-28
DOFEMCRC
Sichuan University
Phase 2 Completed